COMMUNIQUÉS West-GlobeNewswire
-
Applied Biologics Announces Extension of Longstanding System-Wide Agreement With Providence Health & Services for XWRAP®
27/07/2026 -
HealthEx to Help Americans Bring Their Medical Records into AskMD by Sharecare
27/07/2026 -
Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update - Correction
27/07/2026 -
Landmark 10-Year Study Strengthens Long-Term Evidence Supporting Focal Therapy
27/07/2026 -
Rose Hill Life Sciences Appoints Jama Pitman as Chief Executive Officer
27/07/2026 -
HealthEx Launches HealthEx Wallet, a Secure App for Individuals to Access, Understand, and Manage Their Health Records
27/07/2026 -
SafeSpace Global Announces AI-Powered Senior Living Safety Pilot with Blakeford at Green Hills
27/07/2026 -
CurePSP Invests in the Next Generation of PSP and CBD Researchers with Student Fellowship Awards
27/07/2026 -
Assisting Hands Home Care Frisco Trains Caregivers in Stroke Recovery, Brings Post-Stroke Education to North Texas Families
27/07/2026 -
Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel
27/07/2026 -
Oktopi secures follow-on funding to expand OktoPilot's AI-informed capabilities, building on the inaugural global health grant
27/07/2026 -
Vadma Institute Expands Global Practitioner Certification Program as Interest Grows in Its Neuro-Somatic Wellness Method
27/07/2026 -
Parexel Recognized as a World’s Top Disability Inclusive Business by the Disability Index® from Disability:IN
27/07/2026 -
Revagenix Doses First Participant in Phase 1 Trial of Rev-56, an Inhaled Therapy for Non-CF Bronchiectasis
27/07/2026 -
Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process
27/07/2026 -
Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference
27/07/2026 -
FLYTE Partners with 319 Golf Society and Named Exclusive Private Aviation Partner
27/07/2026 -
Oak Hill Bio and Research Alliance Corporation III Announce Business Combination Agreement to Create Publicly Listed Rare Disease Biotechnology Company to Advance Antisense Oligonucleotide Therapy Rugonersen for Angelman Syndrome
27/07/2026 -
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
27/07/2026
Pages